Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

6.4K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.4K
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

245
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
245
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

216
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
216
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

106
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
106
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

127
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
127
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

2.0K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and tolerability of pooled human immune globulins after topical ophthalmic administration in New Zealand White rabbits.

Cutaneous and ocular toxicology·2024
Same author

A Hoechst Reporter Enables Visualization of Drug Engagement <i>In Vitro</i> and <i>In Vivo</i>: Toward Safe and Effective Nanodrug Delivery.

ACS nano·2022
Same author

Development of an Image-Based HCS-Compatible Method for Endothelial Barrier Function Assessment.

SLAS discovery : advancing life sciences R & D·2021
Same author

Structures of human plasma β-factor XIIa cocrystallized with potent inhibitors.

Blood advances·2018
Same author

A Nanoparticle Platform To Evaluate Bioconjugation and Receptor-Mediated Cell Uptake Using Cross-Linked Polyion Complex Micelles Bearing Antibody Fragments.

Biomacromolecules·2016
Same author

The Washington University Central Neuroimaging Data Archive.

NeuroImage·2015

Related Experiment Video

Updated: May 6, 2026

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

4.6K

Combating multidrug-resistant Gram-negative bacterial infections.

Ze-Qi Xu1, Michael T Flavin, John Flavin

  • 1SynChem, Inc. , 1400 Chase Avenue, Elk Grove Village, IL 60007 , USA +1 847 298 2436 ; zq@synchem.com.

Expert Opinion on Investigational Drugs
|November 13, 2013
PubMed
Summary

The search for new antibiotics against multidrug-resistant (MDR) Gram-negative bacteria is critical. Novel strategies beyond traditional analogs are needed to combat these superbugs and fill the antibiotic pipeline.

More Related Videos

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

29.0K
Author Spotlight: Exploring the Antibacterial Effects of Zinc Oxide Nanoparticles in Overcoming Antibiotic Resistance
06:42

Author Spotlight: Exploring the Antibacterial Effects of Zinc Oxide Nanoparticles in Overcoming Antibiotic Resistance

Published on: September 27, 2024

3.0K

Related Experiment Videos

Last Updated: May 6, 2026

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

4.6K
Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

29.0K
Author Spotlight: Exploring the Antibacterial Effects of Zinc Oxide Nanoparticles in Overcoming Antibiotic Resistance
06:42

Author Spotlight: Exploring the Antibacterial Effects of Zinc Oxide Nanoparticles in Overcoming Antibiotic Resistance

Published on: September 27, 2024

3.0K

Area of Science:

  • Microbiology and Infectious Diseases
  • Pharmacology and Drug Discovery
  • Antimicrobial Resistance

Background:

  • Multidrug-resistant (MDR) Gram-negative bacterial infections pose a significant global health threat.
  • Antibiotic development for MDR Gram-negative bacteria has stagnated for decades.

Purpose of the Study:

  • To review recent research and development (R&D) in novel antibiotics against MDR Gram-negative pathogens.
  • To highlight emerging strategies and assess the clinical development status of drug candidates.

Main Methods:

  • Review of R&D activities focusing on new analogs of existing antibiotics (e.g., β-lactams) and novel targets (e.g., aminoacyl-tRNA synthetase).
  • Examination of alternative strategies: cationic antimicrobial peptides, siderophores, efflux pump inhibitors, therapeutic antibodies, and repurposed treatments.
  • Update on the clinical development status of various antibiotic candidates.

Main Results:

  • Traditional analog-based approaches are insufficient against MDR superbugs.
  • Genomics-driven approaches have yielded disappointing results for novel targets.
  • Alternative strategies show promise for overcoming bacterial defense mechanisms.

Conclusions:

  • Novel strategies targeting bacterial cell membranes, influx, efflux, and specific pathogens are crucial.
  • A combination of innovative R&D, supportive policies, and clear regulations is needed to replenish the antibiotic pipeline.
  • Effective armamentarium development is essential for safeguarding global health against antimicrobial resistance.